Revvity ROA 2010-2025 | RVTY

Current and historical return on assets (ROA) values for Revvity (RVTY) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Revvity ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-03-31 $0.29B $12.36B 2.25%
2024-12-31 $0.27B $12.39B 2.08%
2024-09-30 $0.25B $12.77B 1.91%
2024-06-30 $0.17B $13.43B 1.26%
2024-03-31 $0.15B $13.43B 1.10%
2023-12-31 $0.69B $13.57B 4.96%
2023-09-30 $0.74B $13.42B 5.26%
2023-06-30 $0.82B $14.22B 5.76%
2023-03-31 $0.96B $14.64B 6.77%
2022-12-31 $0.57B $14.13B 3.99%
2022-09-30 $0.63B $13.82B 4.36%
2022-06-30 $0.67B $14.19B 4.57%
2022-03-31 $0.74B $14.85B 5.54%
2021-12-31 $0.94B $15.00B 7.96%
2021-09-30 $1.13B $14.90B 11.23%
2021-06-30 $1.18B $8.74B 14.63%
2021-03-31 $1.07B $8.76B 14.20%
2020-12-31 $0.73B $7.96B 10.46%
2020-09-30 $0.41B $6.87B 6.25%
2020-06-30 $0.30B $6.64B 4.53%
2020-03-31 $0.23B $6.38B 3.52%
2019-12-31 $0.23B $6.54B 3.57%
2019-09-30 $0.23B $6.49B 3.75%
2019-06-30 $0.25B $6.40B 4.14%
2019-03-31 $0.25B $6.09B 4.14%
2018-12-31 $0.24B $5.98B 3.98%
2018-09-30 $0.13B $5.86B 2.10%
2018-06-30 $0.14B $5.96B 2.44%
2018-03-31 $0.28B $6.13B 5.19%
2017-12-31 $0.29B $6.09B 5.93%
2017-09-30 $0.40B $4.74B 8.89%
2017-06-30 $0.37B $4.61B 8.35%
2017-03-31 $0.23B $4.34B 5.28%
2016-12-31 $0.23B $4.28B 5.51%
2016-09-30 $0.24B $4.31B 5.62%
2016-06-30 $0.23B $4.19B 5.64%
2016-03-31 $0.22B $4.21B 5.31%
2015-12-31 $0.21B $4.17B 5.20%
2015-09-30 $0.18B $4.03B 4.30%
2015-06-30 $0.16B $4.08B 4.02%
2015-03-31 $0.16B $4.03B 4.08%
2014-12-31 $0.16B $4.13B 3.94%
2014-09-30 $0.19B $3.89B 4.90%
2014-06-30 $0.19B $3.94B 4.86%
2014-03-31 $0.17B $3.97B 4.34%
2013-12-31 $0.17B $3.95B 4.33%
2013-09-30 $0.08B $3.85B 2.19%
2013-06-30 $0.07B $3.81B 1.92%
2013-03-31 $0.08B $3.81B 2.08%
2012-12-31 $0.07B $3.90B 1.84%
2012-09-30 $0.00B $3.89B 0.08%
2012-06-30 $0.01B $3.80B 0.27%
2012-03-31 $0.01B $3.86B 0.16%
2011-12-31 $0.01B $3.86B 0.23%
2011-09-30 $0.39B $3.40B 11.49%
2011-06-30 $0.36B $3.60B 10.90%
2011-03-31 $0.39B $3.31B 12.15%
2010-12-31 $0.39B $3.21B 12.38%
2010-09-30 $0.13B $3.25B 4.20%
2010-06-30 $0.13B $3.15B 4.30%
2010-03-31 $0.10B $3.03B 3.18%
2009-12-31 $0.08B $3.06B 2.78%
Sector Industry Market Cap Revenue
Medical Medical Services $11.610B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.728B 26.96
Elevance Health (ELV) United States $94.145B 12.15
CVS Health (CVS) United States $81.986B 10.19
Cencora (COR) United States $53.983B 18.77
Natera (NTRA) United States $21.477B 0.00
DiDi Global (DIDIY) China $21.462B 32.57
BioMerieux (BMXMF) France $15.263B 0.00
Solventum (SOLV) United States $12.941B 13.70
EUROFINS SCIENT (ERFSF) Luxembourg $12.036B 0.00
Doximity (DOCS) United States $11.396B 59.26
ICON (ICLR) Ireland $11.324B 10.53
CochLear (CHEOY) Australia $11.195B 0.00
Viatris (VTRS) United States $10.516B 3.61
Medpace Holdings (MEDP) United States $9.017B 23.95
Avantor (AVTR) United States $8.859B 12.87
HealthEquity (HQY) United States $8.361B 41.13
Sonic Healthcare (SKHHY) Australia $8.215B 0.00
Charles River Laboratories (CRL) United States $7.027B 13.77
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $4.202B 24.77
BrightSpring Health Services (BTSG) United States $3.894B 36.05
Sotera Health (SHC) United States $3.832B 21.77
Surgery Partners (SGRY) United States $2.982B 38.77
Alignment Healthcare (ALHC) United States $2.952B 0.00
Concentras Parent (CON) United States $2.771B 16.01
Organon (OGN) United States $2.264B 2.41
Ardent Health Partners (ARDT) United States $2.121B 9.04
Premier (PINC) United States $2.101B 14.38
Progyny (PGNY) United States $1.886B 41.51
PACS (PACS) United States $1.698B 0.00
GeneDx Holdings (WGS) United States $1.683B 64.83
GoodRx Holdings (GDRX) United States $1.669B 31.07
Teladoc Health (TDOC) United States $1.289B 0.00
Pediatrix Medical (MD) United States $1.234B 9.39
Agilon Health (AGL) United States $1.229B 0.00
Establishment Labs Holdings (ESTA) $1.000B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.911B 14.23
AMN Healthcare Services Inc (AMN) United States $0.866B 8.11
Embecta (EMBC) United States $0.725B 4.89
QDM (QDMI) Hong Kong, SAR China $0.690B 0.00
Nutex Health (NUTX) United States $0.689B 13.50
Enhabit (EHAB) United States $0.530B 43.58
InnovAge Holding (INNV) United States $0.513B 0.00
Auna S.A (AUNA) Luxembourg $0.513B 13.59
Sonida Senior Living (SNDA) United States $0.512B 0.00
LifeMD (LFMD) United States $0.389B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
SBC Medicals (SBC) United States $0.359B 0.00
Beauty Health (SKIN) United States $0.220B 0.00
Performant Healthcare (PHLT) United States $0.202B 0.00
Oncology Institute (TOI) United States $0.193B 0.00
DocGo (DCGO) United States $0.147B 24.08
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.087B 0.00
Basel Medical Group (BMGL) Singapore $0.087B 0.00
KindlyMD (KDLY) United States $0.082B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.076B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
Biodesix (BDSX) United States $0.053B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
ModivCare (MODV) United States $0.018B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00